- Home
- LVTX vs MYNA Comparison
LVTX vs MYNA Comparison
Compare LVTX & MYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- MYNA
- Stock Information
- Founded
- LVTX 2016
- MYNA 2009
- Country
- LVTX Netherlands
- MYNA Germany
- Employees
- LVTX N/A
- MYNA N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- MYNA
- Sector
- LVTX Health Care
- MYNA
- Exchange
- LVTX Nasdaq
- MYNA Nasdaq
- Market Cap
- LVTX 40.2M
- MYNA 35.9M
- IPO Year
- LVTX 2021
- MYNA 2021
- Fundamental
- Price
- LVTX $1.48
- MYNA $1.40
- Analyst Decision
- LVTX Strong Buy
- MYNA
- Analyst Count
- LVTX 2
- MYNA 0
- Target Price
- LVTX $6.00
- MYNA N/A
- AVG Volume (30 Days)
- LVTX 56.8K
- MYNA 36.1K
- Earning Date
- LVTX 12-03-2024
- MYNA 11-26-2024
- Dividend Yield
- LVTX N/A
- MYNA N/A
- EPS Growth
- LVTX N/A
- MYNA N/A
- EPS
- LVTX N/A
- MYNA N/A
- Revenue
- LVTX $7,398,000.00
- MYNA $5,957,776.00
- Revenue This Year
- LVTX N/A
- MYNA $216.03
- Revenue Next Year
- LVTX N/A
- MYNA $267.22
- P/E Ratio
- LVTX N/A
- MYNA N/A
- Revenue Growth
- LVTX N/A
- MYNA 21.89
- 52 Week Low
- LVTX $1.35
- MYNA $0.66
- 52 Week High
- LVTX $6.47
- MYNA $7.58
- Technical
- Relative Strength Index (RSI)
- LVTX 35.08
- MYNA 51.18
- Support Level
- LVTX $1.54
- MYNA $1.30
- Resistance Level
- LVTX $1.65
- MYNA $1.48
- Average True Range (ATR)
- LVTX 0.11
- MYNA 0.09
- MACD
- LVTX -0.04
- MYNA 0.01
- Stochastic Oscillator
- LVTX 3.92
- MYNA 45.45
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About MYNA Mynaric AG American Depository Shares
Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.